When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Chlorphenamine - Wikipedia

   en.wikipedia.org/wiki/Chlorphenamine

   Chlorpheniramine was patented in 1948 and came into medical use in 1949. [3] It is available as a generic medication and over the counter. [2] [4] In 2022, it was the 291st most commonly prescribed medication in the United States, with more than 400,000 prescriptions. [5] [6]

3. Pramlintide - Wikipedia

   en.wikipedia.org/wiki/Pramlintide

   Pramlintide has been approved on 3/16/2005 by the FDA, for use by type 1 and type 2 diabetic patients who use insulin. [6] (subscription required) Pramlintide allows patients to use less insulin, lowers average blood sugar levels, and substantially reduces what otherwise would be a large unhealthy rise in blood sugar that occurs in diabetics right after eating.

4. Diabetes medication - Wikipedia

   en.wikipedia.org/wiki/Diabetes_medication

   Type 2 diabetes is the most common type of diabetes. Treatments include agents that (1) increase the amount of insulin secreted by the pancreas, (2) increase the sensitivity of target organs to insulin, (3) decrease the rate at which glucose is absorbed from the gastrointestinal tract, and (4) increase the loss of glucose through urination.

5. Epalrestat - Wikipedia

   en.wikipedia.org/wiki/Epalrestat

   Epalrestat is a carboxylic acid derivative [1] and a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy, which is one of the most common long-term complications in patients with diabetes mellitus.

6. Loratadine - Wikipedia

   en.wikipedia.org/wiki/Loratadine

   Loratadine, sold under the brand name Claritin among others, is a medication used to treat allergies. [5] This includes allergic rhinitis (hay fever) and hives. [5] It is also available in drug combinations such as loratadine/pseudoephedrine, in which it is combined with pseudoephedrine, a nasal decongestant. [5]

7. Rosiglitazone - Wikipedia

   en.wikipedia.org/wiki/Rosiglitazone

   The study found an overall 1.4 fold increase in risk of cardiovascular ischemic events relative to the control arms. The results were heterogenous, with clear evidence of increased risk relative to placebo but not relative to other diabetes treatments and higher risk associated with combinations of rosiglitazone with insulin or metformin. [28]